Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Stock Quotes and News

Alexion Pharmaceuticals, Inc. (ALXN) 93.06 1.07

Price Open:	91.50	Day's Range:	81.51000 - 116.40500
Price Close:	91.32	52wk Range:	62.02 - 119.54
Price Day Change:	1.07	Volume:	912,649
Price % Change:	1.17	Market Cap:	18.030B
Bid:	92.39000	PE Ratio:	62.68
Ask:	93.06000	EPS Diluted:	1.457

Trade ALXN NOW!

The Latest On ALXN

Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19 6/18/13 10:39am

Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB) 6/12/13 1:29pm

UPDATE: Credit Suisse Initiates Alexion Pharmaceuticals at Neutral Awaiting Near-Term Catalyst 5/31/13 9:39am

Short Interest in Vertex Rises, in Biogen Idec Falls 5/29/13 1:19pm

FDA Grants Breakthrough Therapy Designation to Asfotase Alfa for Perinatal-, Infantile- and Juvenile-Onset Hypophosphatasia 5/28/13 7:03am

Short Interest in Vertex Rises, in Celgene Falls 5/11/13 10:45am

Short Sellers Move into Celgene, Regeneron 4/26/13 1:25pm

Short Sellers Move Out of Amgen, Celgene, Pharmacyclics 4/10/13 1:30pm

Buy Alexion on Weakness After FDA Warning Letter, Suggest Piper Jaffray Analyst 3/28/13 10:33am

Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences 3/28/13 8:18am

Moving Averages Indicate These Sector ETFs Could be Stretched 3/25/13 5:33pm

Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC) 3/12/13 1:19pm

Press Releases

Alexion Breaks Ground on New Global Headquarters 6/17/13 Business Wire

Alexion to Present at the Wells Fargo 2013 Healthcare Conference 6/12/13 Business Wire

Alexion Update Regarding Presentations at Investor Conferences 6/10/13 Business Wire

Alexion to Present at Investor Conferences 6/5/13 Business Wire

Alexion to Present at the Jefferies 2013 Global Healthcare Conference 5/30/13 Business Wire

FDA Grants Breakthrough Therapy Designation to Asfotase Alfa for Perinatal-, Infantile- and Juvenile-Onset Hypophosphatasia (HPP) 5/28/13 Business Wire

Alexion to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 5/23/13 Business Wire

Critical Alerts For Wells Fargo, Alexion Pharmaceuticals, Cigna, Deckers Outdoor, and Yelp Released By InvestorsObserver 5/20/13 Newswire

Alexion to Present at the BofA Merrill Lynch 2013 Healthcare Conference 5/8/13 Business Wire

Alexion Reports First Quarter 2013 Results 4/25/13 Business Wire

Alexion Broadens and Strengthens its Executive Leadership Team 4/25/13 Business Wire

Alexion Pharmaceuticals to Report First Quarter 2013 Results on Thursday, April 25, 2013 4/11/13 Business Wire

Get the latest ALXN stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Alexion Pharmaceuticals, Inc. stock price.

Partner Headlines

Amgen Xgeva Label Expanded - Analyst Blog 6/17/13

Myriad: End to Legal Battle over Patents - Analyst Blog 6/17/13

Amgen's Oncology Drug Meets Primary Endpoint - Analyst Blog 6/13/13

Myriad's Bearish Dive Shows Biotech Leaders Stalling 6/13/13

Encouraging Data on Alexion's Soliris - Analyst Blog 6/10/13

Encouraging data from Bristol-Myers - Analyst Blog 6/5/13

Celgene Presents Data at ASCO - Analyst Blog 6/5/13

CHMP Backs Celgene's Pomalyst - Analyst Blog 6/3/13

Stocks Rebound To End Higher; GII Jumps After Hours 6/3/13

Stock Market Closes Higher As Indexes Erase Losses 6/3/13

Stocks Mixed In Late Trade; Stratasys, 3D Plunge 6/3/13